We demonstrate that a novel, potent MNK inhibitor ETC-168 can effectively block p-4E and transcription of E2F1, FOXM1, and WEE1, along with its antiproliferative activity in STS cells. This evidence concerns the gene E2F1 and telomere syndrome.